18F-FDG PET-CT imaging for treatment evaluation in lymphoma

VernacularTitle:18F-FDG PET-CT显像在淋巴瘤疗效评价中的应用
Author: Jin YAN ; Jianwei YANG ; Peng LI
Publication Type:Journal Article
Keywords: Lymphoma; Radionuclide imaging; Evaluation studies
From: Journal of Leukemia & Lymphoma 2009;18(10):622-623,629
CountryChina
Language:Chinese
Abstract: Objective To investigate the clinical value of PET-CT scans in lymphomatous patients in post-therapy evaluation. Methods 18F-FDG PET-CT imaging were performed in 40 lymphomatous patients whom had been received therapy. Successive PET-CT imaging were performed in 5 cases, and the treatment was evaluated with clinical evaluation. Results Successive PET-CT imaging were performed in 5 cases, in which the tumor was eradicated in 2 cases, improved in 2 cases, and relapsed in 1 case. In 35 patients PET-CT imaging was repeated after treatment, among them 30 cases with complete or partial remission, and PET-CT imaging was positive in 25 cases. PET-CT imaging was still positive in 8 cases with recurrent or remnant tumor. PET-CT imaging changed the therapeutic regime. Conclusion PET-CT imaging can detect the recurrent or remnant tumor sensitively and accurately. There is a significant value for the guidance of clinical therapeutic.